Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve 1. The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025.\r\n2. The Interim Dividend, if any, for the financial year 2025-2026.\r\n